Genedx Holdings Corp Stock Revenue
| WGS Stock | 78.71 6.64 9.21% |
GeneDx Holdings Corp fundamentals help investors to digest information that contributes to GeneDx Holdings' financial success or failures. It also enables traders to predict the movement of GeneDx Stock. The fundamental analysis module provides a way to measure GeneDx Holdings' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to GeneDx Holdings stock.
| Last Reported | Projected for Next Year | ||
| Total Revenue | 202.6 M | 225.5 M |
GeneDx | Revenue |
GeneDx Holdings Corp Company Revenue Analysis
GeneDx Holdings' Revenue is income that a firm generates from business activities such us rendering services or selling goods to customers. It is a crucial part of a business and an essential item when evaluating a company's financial statements. Revenues from a firm's primary business operations can be reported on the income statement as sales revenue, net sales, or simply sales, depending on the industry in which a given company operates.
Current GeneDx Holdings Revenue | 202.57 M |
Most of GeneDx Holdings' fundamental indicators, such as Revenue, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, GeneDx Holdings Corp is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Historical and Projected quarterly revenue of GeneDx
Projected quarterly revenue analysis of GeneDx Holdings Corp provides investors and stakeholders with an insight into the company's performance and growth prospects. When actual revenues of GeneDx Holdings match or exceed analyst estimates, it positively influences investor confidence and market perception, often leading to a rise in GeneDx Holdings' stock price.
GeneDx Revenue Driver Correlations
Understanding the fundamental principles of building solid financial models for GeneDx Holdings is extremely important. It helps to project a fair market value of GeneDx Stock properly, considering its historical fundamentals such as Revenue. Since GeneDx Holdings' main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of GeneDx Holdings' historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of GeneDx Holdings' interrelated accounts and indicators.
| -0.83 | -0.8 | 0.52 | 0.16 | 0.72 | ||
| -0.83 | 0.76 | -0.61 | -0.44 | -0.65 | ||
| -0.8 | 0.76 | -0.01 | 0.18 | -0.96 | ||
| 0.52 | -0.61 | -0.01 | 0.82 | -0.1 | ||
| 0.16 | -0.44 | 0.18 | 0.82 | -0.24 | ||
| 0.72 | -0.65 | -0.96 | -0.1 | -0.24 |
Click cells to compare fundamentals
GeneDx Revenue Historical Pattern
Today, most investors in GeneDx Holdings Stock are looking for potential investment opportunities by analyzing not only static indicators but also various GeneDx Holdings' growth ratios. Consistent increases or drops in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's revenue growth rates may not be enough to decide which company is a better investment. That's why investors frequently use a static breakdown of GeneDx Holdings revenue as a starting point in their analysis.
GeneDx Holdings Revenue |
| Timeline |
Revenue is typically recorded when cash or cash equivalents are exchanged for services or goods and can include products or services discounts, promotions, as well as early payments on invoices or services rendered in advance.
| Competition |
GeneDx Current Deferred Revenue
Current Deferred Revenue |
|
Based on the latest financial disclosure, GeneDx Holdings Corp reported 202.57 M of revenue. This is 97.34% lower than that of the Health Care Equipment & Supplies sector and significantly higher than that of the Health Care industry. The revenue for all United States stocks is 97.85% higher than that of the company.
GeneDx Revenue Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses GeneDx Holdings' direct or indirect competition against its Revenue to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of GeneDx Holdings could also be used in its relative valuation, which is a method of valuing GeneDx Holdings by comparing valuation metrics of similar companies.GeneDx Holdings is currently under evaluation in revenue category among its peers.
GeneDx Holdings ESG Sustainability
Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, GeneDx Holdings' sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to GeneDx Holdings' managers, analysts, and investors.Environmental | Governance | Social |
GeneDx Fundamentals
| Return On Equity | -0.36 | ||||
| Return On Asset | -0.0827 | ||||
| Profit Margin | (0.31) % | ||||
| Operating Margin | (0.10) % | ||||
| Current Valuation | 1.98 B | ||||
| Shares Outstanding | 27.47 M | ||||
| Shares Owned By Insiders | 18.20 % | ||||
| Shares Owned By Institutions | 70.24 % | ||||
| Number Of Shares Shorted | 2.6 M | ||||
| Price To Book | 9.68 X | ||||
| Price To Sales | 7.41 X | ||||
| Revenue | 202.57 M | ||||
| Gross Profit | (26.75 M) | ||||
| EBITDA | (136.46 M) | ||||
| Net Income | (175.77 M) | ||||
| Total Debt | 119.77 M | ||||
| Book Value Per Share | 7.45 X | ||||
| Cash Flow From Operations | (180.15 M) | ||||
| Short Ratio | 3.56 X | ||||
| Earnings Per Share | (3.09) X | ||||
| Target Price | 80.83 | ||||
| Number Of Employees | 1 K | ||||
| Beta | 2.18 | ||||
| Market Capitalization | 1.98 B | ||||
| Total Asset | 473.67 M | ||||
| Retained Earnings | (1.3 B) | ||||
| Working Capital | 123.52 M | ||||
| Net Asset | 473.67 M |
About GeneDx Holdings Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze GeneDx Holdings Corp's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of GeneDx Holdings using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of GeneDx Holdings Corp based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for GeneDx Stock Analysis
When running GeneDx Holdings' price analysis, check to measure GeneDx Holdings' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy GeneDx Holdings is operating at the current time. Most of GeneDx Holdings' value examination focuses on studying past and present price action to predict the probability of GeneDx Holdings' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move GeneDx Holdings' price. Additionally, you may evaluate how the addition of GeneDx Holdings to your portfolios can decrease your overall portfolio volatility.